Advertisement

Related Videos

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Deborah Collyar: What's In It for Patients?

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Advertisement

Advertisement




Apr
01
Today In Oncology
Molecular Test Doubles Detection of Bile Duct Cancer
‘Prostate Screening Saved My Life’—Is That Really True in Most Cases?
Adjuvant Pembrolizumab Plus Belzutifan in Patients With RCC at Increased Risk of Recurrence
Risk of Subsequent Cancer in Solid Organ Transplant Recipients With Pretransplant Cancer History
Elinzanetant May Reduce Side Effects of Endocrine Therapy Among Patients With Breast Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo